The results revealed that the combination therapy (AdhTERTHRP + AdCMVmIL-12) led to extensive tumor infiltration by CD4+ T cells (P < 0.0001, 9.4-fold) and CD8+ T cells (P < 0.0001, 8.6-fold) compared with AdCMV(-) group. Here, CD4 is linked to neoplasm.